Trials
Improving diverse patient enrollment in clinical trials, focusing on Hispanic and Asian populations: recommendations from an interdisciplinary expe...
Competing interests: BP has received grants from Tesaro/GSK, Merck, Astra Zeneca, Karyopharm Therapeutics, Incyte, Toray, VBL Therapeutics, InxMed,...
Stakeholder Engagement in Eight Comparative Effectiveness Trials in African Americans and Latinos With Asthma
…widely reported. In 2014, eight comparative effectiveness studies targeting African Americans and Hispanics/Latinos with uncontrolled asthma...
US FDA expands guidance on race, ethnicity data in trials
…standards for classifying race and ethnicity data, the U.S. FDA issued
Source link
Minority Populations Largely Unrepresented in Gynecologic Cancer Clinical Trials
New research further revealed disparities in gynecologic cancer clinical trial enrollment, warranting increased efforts to improve representation i...
UCSD Investigator Secures $4m to Implement Intervention to Recruit more Hispanic/Latino Pediatric Cancer Patients into Clinical Trials
UCSD Investigator Secures $4m to Implement Intervention to Recruit more Hispanic/Latino Pediatric Cancer Patients into Clinical Trials
Source link
The inclusion of pregnant women in vaccine clinical trials: An overview of late-stage clinical trials' records between 2018 and 2023
Pregnant women are generally excluded from clinical research over safety concerns. However, demands to include them in clinical vaccine development...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
